annb0t
Top 20
MELBOURNE, Australia, Nov. 11, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company), a commercial-stage biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic radiopharmaceuticals, advises that Dr Christian Behrenbruch, Group CEO and Managing Director, will be presenting at the Jefferies London Healthcare Conference 2022. (PRNewsfoto/Telix Pharmaceuticals Limited)
The presentation will take place on Thursday 17...
>>> Read more: Telix to Present at Jefferies London Healthcare Conference 2022
The presentation will take place on Thursday 17...
>>> Read more: Telix to Present at Jefferies London Healthcare Conference 2022
